3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Lymphoma
9
Hodgkin Disease
7
Testicular Neoplasms
3
Teratoma
3
Lymphoma, Large B-Cell, Diffuse
3
Recurrence
2
Ovarian Neoplasms
2
Ovarian Germ Cell Cancer
2
Warts
1
Vulvar Neoplasms
1
Testicular Germ Cell Tumor
1
Stomach Neoplasms
1
Sertoli-Leydig Cell Tumor
1
Seminoma
1
Sarcoma, Kaposi
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pathologic Processes
1
Ovarian gynandroblastoma
1
Neoplastic Processes
1
Neoplasms
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large-Cell, Immunoblastic
1
Intracranial Non-germinomatous Germ Cell Tumor
1
Head and Neck Neoplasms
1
HIV Infections
1
Granulosa cell tumor of the ovary
1
Germinoma
1
Endodermal Sinus Tumor
1
Interventions
Oxaliplatin
47
Capecitabine
46
Fluorouracil
40
Leucovorin
30
Radiotherapy
25
Irinotecan
20
Chemoradiotherapy
14
Bevacizumab
14
Cetuximab
12
Neoadjuvant Therapy
11
Folfox protocol
11
Chemotherapy, Adjuvant
11
XELOX
10
Laparoscopy
10
Drug Therapy
9
Surgical Procedures, Operative
6
Robotic Surgical Procedures
5
Radiation
5
Mastectomy, Segmental
5
Surveys and Questionnaires
4
Radiotherapy, Intensity-Modulated
4
Panitumumab
4
Gemcitabine
4
FOLFOXIRI protocol
4
durvalumab
3
Simvastatin
3
Magnetic Resonance Spectroscopy
3
Indocyanine Green
3
tislelizumab
2
regorafenib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Rectal Neoplasms
×
Bleomycin
×
Clear all
NCT03040180
2019-01-25
nECT
Zealand University Hospital
Phase 2
Unknown
40 enrolled